ARTICLE | Regulation
Congo, three other countries license Merck’s Ebola vaccine
February 15, 2020 12:44 AM UTC
As biopharmas gear up to develop vaccines and therapies for COVID-19, four African countries at risk from the Ebola outbreak approved and licensed a vaccine from Merck & Co. Friday.
The Democratic Republic of the Congo, Burundi, Ghana and Zambia licensed Ervebo from Merck & Co. Inc. (NYSE:MRK), which allows the pharma to stockpile and distribute the vaccine. Merck said it expects doses of the vaccine to be available in 3Q20...
BCIQ Company Profiles